Kuwata Yoshihiro, Muneuchi Gan, Igawa Hiroharu H, Tsukuda Fumio, Inui Masashi, Kakehi Yoshiyuki
Department of Urology, Kagawa University, Faculty of Medicine, Kagawa, Japan.
Int J Urol. 2007 Jun;14(6):510-4. doi: 10.1111/j.1442-2042.2006.01695.x.
We prospectively investigated health-related quality of life (HR-QOL), including sexual function and sexual bother, in patients who underwent nerve grafting during a radical prostatectomy in comparison with those who underwent a non-nerve-sparing radical prostatectomy.
Between August 2001 and May 2004, radical prostatectomies were performed on 69 patients with clinical T1-T2N0/M0 prostate cancer. Of these, 66 patients (22: nerve-grafting patients, 44: non-nerve-sparing and non-nerve-grafting patients) were enroled into this study. The observation periods ranged from 12-46 months (median: 29 months). The general HR-QOL was measured with the SF-36 General Health Survey and disease-specific HR-QOL was measured with the University of California Los Angeles-Prostate Cancer Index.
Penile tumescence was observed in 11 out of 15 (73.3%) prostate-specific antigen failure-free patients who underwent unilateral nerve grafting with contra-lateral nerve-sparing or bilateral nerve grafting. Vaginal penetration was observed in six out of 15 (40.0%) patients. The time for partial erection and for intercourse, respectively, ranged from 3-21 months (median = 6 months) and 6-36 months (median = 13.5 months). There were no significant differences in general HR-QOL changes over time between the nerve-grafting patients and the patients without any nerve-preserving procedures. The sexual function score was significantly better in the nerve-grafting (bilateral nerve graft or unilateral nerve graft with contra-lateral nerve-sparing) patients than in the non-nerve-sparing/non-nerve-grafting patients. The sexual bother score, however, was more serious for the patients who underwent nerve-grafting surgery than for the non-nerve-sparing/non-nerve-grafting patients.
Sexual bother is serious for patients who attempt to maintain sexual function after special surgical procedures, such as nerve-grafting surgery. We should be aware that careful counseling is needed to avoid impatient and excessive hope for the recovery of sexual function.
我们前瞻性地研究了在根治性前列腺切除术中接受神经移植的患者与接受非保留神经根治性前列腺切除术的患者的健康相关生活质量(HR-QOL),包括性功能和性困扰。
在2001年8月至2004年5月期间,对69例临床T1-T2N0/M0前列腺癌患者进行了根治性前列腺切除术。其中,66例患者(22例:神经移植患者,44例:非保留神经且非神经移植患者)纳入本研究。观察期为12-46个月(中位数:29个月)。采用SF-36健康调查量表测量总体HR-QOL,采用加利福尼亚大学洛杉矶分校前列腺癌指数测量疾病特异性HR-QOL。
在15例接受单侧神经移植加对侧神经保留或双侧神经移植且无前列腺特异性抗原复发的患者中,有11例(73.3%)观察到阴茎勃起。15例患者中有6例(40.0%)观察到阴道插入。部分勃起时间和性交时间分别为3-21个月(中位数=6个月)和6-36个月(中位数=13.5个月)。神经移植患者与未进行任何神经保留手术的患者在总体HR-QOL随时间的变化上无显著差异。神经移植(双侧神经移植或单侧神经移植加对侧神经保留)患者的性功能评分显著优于非保留神经/非神经移植患者。然而,接受神经移植手术的患者的性困扰评分比非保留神经/非神经移植患者更严重。
对于在特殊手术(如神经移植手术)后试图维持性功能的患者,性困扰较为严重。我们应该意识到,需要进行仔细的咨询,以避免对性功能恢复产生不耐烦和过度的期望。